Global Precision Medicine Market
Dublin, Nov. 03, 2022 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market by Technology, Application, and Region - Size, Share, Outlook, and Opportunity Analysis 2019-2027" report has been added to ResearchAndMarkets.com's offering.
Precision medicine guides disease diagnosis, treatment, and prevention of cancer, hereditary diseases, and other disorders based on an individual's unique clinical, molecular, and lifestyle information. Doctors and researchers will be able to predict more accurately which treatment and prevention methods for a specific disease will work in which groups of people using this approach.
Through the use of pharmacogenomics, which analyses patient data to guide effective and safe medication plans for patients, precision medicine has the potential to enhance population health and lower overall healthcare costs. The detailed characterization of human biology is now possible owing to innovations in biomarkers, bioimaging, and wearable technologies. Clinicians employ a combination of genomic data, health records, lab tests, and other patient data to help personalise therapy in precision medicine. In this way they will be able to offer the appropriate treatment to the appropriate patient at the appropriate time.
The increasing adoption of inorganic strategies such as collaborations and partnerships by the key players in the market is expected to drive the global precision medicine market over the forecast period.
For instance, in September 2020, Thermo Fisher Scientific Inc., the world leader in serving science, announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca, a multinational pharmaceutical and Biotechnology Company, and the University of Nebraska Medical Center, a public medical school in Omaha, Nebraska. The new collaboration will help strengthen the PMSC's mission of creating standardized workflows with pharma and academic partners to create new opportunities for precision medicine.
Global Precision Medicine Market, By Technology:
Precision Molecular Diagnostics
Big Data Analytics
Global Precision Medicine Market, By Application:
Central Nervous System
Global Precision Medicine Market, By Region:
Rest of Latin America
Rest of Europe
Rest of Asia Pacific
Rest of Middle East
Tepnel Pharma Services Limited
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
Hoffmann-La Roche Ltd
Eli Lilly & Company
Myriad Genetics, Inc.
Bristol-Myers Squibb Company
Foundation Medicine, Inc.
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Precision Medicine Market- COVID-19 Impact Analysis
5. Global Precision Medicine Market, By Technology, 2017 - 2030, (US$ Million)
6. Global Precision Medicine Market, By Application, 2017 - 2030, (US$ Million)
7. Global Precision Medicine Market, By Region, 2017 - 2030, (US$ Million)
8. Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/izqcyd
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900